Cardiology
RSSArticles
-
Late-Breaking Trials from the European Society of Cardiology Congress in Vienna, Austria: CHARM
The 3 CHARM studies (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) and their combined results were presented at the ESC meeting and published in Lancet in September. -
Full November 2003 Issue in PDF
-
Depressed Platelets
Sertraline contributed to a decrease in platelet activation over and above either aspirin or thienopyridines, and the SSRI might represent an attractive additional advantage for patients with depression and comorbid coronary artery disease and stroke. -
Late-Breaking Trials from the European Society of Cardiology Congress: TAXUS IV
Drs. Gregg Stone and Stephen Ellis presented the 9-month clinical and angiographic results from TAXUS IV, which was designed to assess the safety and efficacy of the TAXUS slow-release polymer-based paclitaxel-eluting Express2 stent (Boston Scientific) in a broad cross-section of patients. -
Antibiotic-Resistant Foodborne Illness: More than ‘Meats’ the Eye?
Marcolina S. Antibiotic-resistant foodborne illness: More than 'meats' the eye. Altern Med Alert 2003;6(11):128-131. -
Full November 2003 Issue in PDF
-
Exercise and Arthritis
Exercise and arthritis. Altern Med Alert 2003;6(suppl 11):S1-S2. -
Clinical Briefs: Acupuncture for Labor Pain
Greenfield R. Acupuncture for labor pain. Altern Med Alert 2003;6(11):131-132. -
Passionflower Liquid Extract for Anxiety
Brinker F. Passionflower liquid extract for anxiety. Altern Med Alert 2003;6(11):125-128. -
Glucosamine for Osteoarthritis: An Update
Kolasinski S. Glucosamine for osteoarthritis: An update. Altern Med Alert 2003;6(11):121-125.